Patents by Inventor Ping Cao

Ping Cao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11950484
    Abstract: A display panel includes a display layer, a photosensitive layer and an infrared mask. The display layer is configured to display an image, the display layer has light-transmitting portions, and the light-transmitting portions are configured to transmit infrared light. The photosensitive layer is disposed on a side of the display layer. The infrared mask is disposed on a side of the photosensitive layer proximate to the display layer, the infrared mask has hollowed-out regions, the hollowed-out regions are configured to make the infrared mask have a preset pattern, and a region in the infrared mask except the hollowed-out regions is configured to prevent transmission of the infrared light. The photosensitive layer is configured to receive infrared light passing though the hollowed-out regions and the light-transmitting portions, and convert the infrared light into an image signal.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: April 2, 2024
    Assignee: BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Pengpeng Wang, Haisheng Wang, Xiaoliang Ding, Yangbing Li, Xueyou Cao, Ping Zhang, Likai Deng, Yubo Wang
  • Publication number: 20240082197
    Abstract: The present invention relates to the delivery method of Omega-3's and nutritional supplements for the human diet used to aid mental and visual development of human embryos as well as enhance visual acuity and mental fitness in humans. The invention contains vitamins, minerals, and microencapsulated fish oil powder containing DHA and EPA.
    Type: Application
    Filed: September 18, 2023
    Publication date: March 14, 2024
    Inventors: Thuong Cao Do, Ping Yang
  • Publication number: 20240065445
    Abstract: The present application relates to the technical field of sofa, and in particular to a compact sofa frame structure, including a base frame and a slidable frame. The base frame is provided with an adjusting assembly. The adjusting assembly includes a driving rod and a driven rod; in which the driving rod and the driven rod are both rotatably connected at one end thereof on the base frame and rotatably connected to the backrest at the other end thereof; a linkage rod rotatably connected on the driving rod; the frame is provided with a driving assembly configured to drive a leg rest rotatably connected on the slidable frame to rotate; the slidable frame is provided with a fixing rod configured to limit the leg rest.
    Type: Application
    Filed: May 26, 2023
    Publication date: February 29, 2024
    Inventors: Yuanfeng FENG, Jizhong CAO, Jundong GAO, Ping WANG
  • Patent number: 11895522
    Abstract: A method includes: A first device sends a first signal to a second device, where the first signal includes a first transmit signal and a first pilot signal; the first device obtains a second signal, where the second signal includes a first self-interference signal, a second pilot signal, and a second receive signal from the second device; the first device extracts jitter information of the first self-interference signal based on the first pilot signal and the second pilot signal; the first device reconstructs a self-interference signal based on the first transmit signal and the jitter information of the first self-interference signal, to obtain a cancellation signal of the first self-interference signal; and the first device cancels the first self-interference signal from the second receive signal based on the cancellation signal of the first self-interference signal.
    Type: Grant
    Filed: May 6, 2021
    Date of Patent: February 6, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Meng Cai, Kun Li, Jiantao Ma, Ping Cao, Hongli Jiang
  • Publication number: 20230286904
    Abstract: Disclosed herein are synthesis and use of covalent inhibitors selective for Transcriptional Enhancer Factor TEF-1 (TEAD1), which can be used for treatment of cancers such as glioblastoma, gastric cancer, colorectal cancer, pancreatic ductal adenocarcinoma (PDAC), and malignant pleural mesothelioma (MPM). Further disclosed herein are pharmaceutical compositions including the TEAD1 inhibitor and methods of treating cancers using the same.
    Type: Application
    Filed: July 2, 2021
    Publication date: September 14, 2023
    Inventors: Chao ZHANG, Michael J. BISHOP, Hang CHEN, Ping CAO
  • Patent number: 11740672
    Abstract: A multiport USB-PD adaptor including a flyback-converter, a USB controller including a USB-PD subsystem and buck-controller, and multiple buck and bypass-circuits, and methods for operating the same are provided. Generally, the adaptor is operated in a buck-bypass-mode, in which at least one buck-circuit is bypassed and the flyback-converter is operated to generate an input voltage (VIN) to the buck-circuits equal to a requested output voltage (VOUT_C), which is then coupled directly to the associated port. Buck-circuits coupled to other active ports can also be bypassed if the requested VOUT_Cs are the same, or the buck-circuits operated to provide another VOUT_C. If a bypass-circuit unavailable, the adaptor is operated in a variable-buck-input-mode by determining a highest VOUT_C requested on any port and setting VIN to a sum of the highest VOUT_C and an offset voltage. Buck-circuits coupled to active ports are then operated to provide the requested output voltages.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: August 29, 2023
    Assignee: Cypress Semiconductor Corporation
    Inventors: Chuan-yu Lin, Jen-Hui Cheng, Hua-ping Cao, Yong-shuang Zhu, Hsiang-Nien Kuo
  • Publication number: 20220350388
    Abstract: A multiport USB-PD adaptor including a flyback-converter, a USB controller including a USB-PD subsystem and buck-controller, and multiple buck and bypass-circuits, and methods for operating the same are provided. Generally, the adaptor is operated in a buck-bypass-mode, in which at least one buck-circuit is bypassed and the flyback-converter is operated to generate an input voltage (VIN) to the buck-circuits equal to a requested output voltage (VOUT_C), which is then coupled directly to the associated port. Buck-circuits coupled to other active ports can also be bypassed if the requested VOUT_Cs are the same, or the buck-circuits operated to provide another VOUT_C. If a bypass-circuit unavailable, the adaptor is operated in a variable-buck-input-mode by determining a highest VOUT_C requested on any port and setting VIN to a sum of the highest VOUT_C and an offset voltage. Buck-circuits coupled to active ports are then operated to provide the requested output voltages.
    Type: Application
    Filed: July 28, 2021
    Publication date: November 3, 2022
    Applicant: Cypress Semiconductor Corporation
    Inventors: Chuan-yu Lin, Jen-Hui Cheng, Hua-ping Cao, Yong-shuang Zhu, Hsiang-Nien Kuo
  • Publication number: 20220288069
    Abstract: The present disclosure provides compounds and compositions thereof which are useful as inhibitors of tyrosine kinase and which exhibit desirable characteristics for the same. Further disclosed herein are methods of treating cancer using these tyrosine kinase inhibitor compounds.
    Type: Application
    Filed: July 17, 2020
    Publication date: September 15, 2022
    Inventors: Chao Zhang, Ping Cao, Michael J. Bishop
  • Publication number: 20220276253
    Abstract: The present disclosure provides a profiling method based on comparative mass spectrometry analysis for identifying and quantifying the covalent interactions of electrophilic compounds with diverse proteins in complex proteomes, as well as compositions for performing the method.
    Type: Application
    Filed: August 4, 2020
    Publication date: September 1, 2022
    Inventors: Ping Cao, Yuan Yuan, Chao Zhang
  • Publication number: 20220218703
    Abstract: The disclosure provides novel FGFR inhibitors based on the pyridinylpyrimidine. The disclosure includes inhibitors with broad inhibitory activity against all FGFR isoforms, and inhibitors with selective inhibition against FGFR4. These novel pyridinylpyrimidine-based FGFR inhibitors, or their derivatives, have strong potential to be used to treat cancer.
    Type: Application
    Filed: February 14, 2020
    Publication date: July 14, 2022
    Inventors: Ping Cao, Chao Zhang, Michael J. Bishop
  • Publication number: 20210258816
    Abstract: A method includes: A first device sends a first signal to a second device, where the first signal includes a first transmit signal and a first pilot signal; the first device obtains a second signal, where the second signal includes a first self-interference signal, a second pilot signal, and a second receive signal from the second device; the first device extracts jitter information of the first self-interference signal based on the first pilot signal and the second pilot signal; the first device reconstructs a self-interference signal based on the first transmit signal and the jitter information of the first self-interference signal, to obtain a cancellation signal of the first self-interference signal; and the first device cancels the first self-interference signal from the second receive signal based on the cancellation signal of the first self-interference signal.
    Type: Application
    Filed: May 6, 2021
    Publication date: August 19, 2021
    Inventors: Meng CAI, Kun LI, Jiantao MA, Ping CAO, Hongli JIANG
  • Patent number: 10683333
    Abstract: Isolated non-naturally occurring, mutant-human islet amyloid polypeptides (hIAPP) are disclosed. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. Methods and compositions for treating amyloid-based disease in a subject in need thereof, by administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof are also disclosed.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: June 16, 2020
    Assignee: The Research Foundation for The State University of New York
    Inventors: Daniel Raleigh, Hui Wang, Ping Cao, Andisheh Abedini
  • Patent number: 10319728
    Abstract: In some examples, a fluid ejection device includes a substrate and a memory cell on the substrate, the memory cell including a first dielectric layer, a floating gate, a second dielectric layer, and a control gate. The memory cell includes a channel region between a drain region and a source region. The first dielectric layer is over the channel region and the floating gate is capacitively coupled to the channel region through the first dielectric layer. The floating gate includes a polysilicon layer, a metal layer, and a second dielectric layer between the polysilicon layer and the metal layer, where the second dielectric layer includes an opening through which the polysilicon layer is electrically connected to the metal layer.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: June 11, 2019
    Assignee: HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.
    Inventors: Chaw Sing Ho, Reynaldo V. Villavelez, Xin Ping Cao
  • Publication number: 20180319860
    Abstract: Isolated non-naturally occurring, mutant-human islet amyloid polypeptides (hIAPP) are disclosed. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. Methods and compositions for treating amyloid-based disease in a subject in need thereof, by administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof are also disclosed.
    Type: Application
    Filed: July 11, 2018
    Publication date: November 8, 2018
    Applicant: The Research Foundation for The State University of New York
    Inventors: Daniel RALEIGH, Hui WANG, Ping CAO, Andisheh ABEDINI
  • Patent number: 10072060
    Abstract: Isolated non-naturally occurring, mutant-human islet amyloid polypeptides (hIAPP) are disclosed. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. Methods and compositions for treating amyloid-based disease in a subject in need thereof, by administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof are also disclosed.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: September 11, 2018
    Assignee: The Research Foundation for The State University of New York
    Inventors: Daniel Raleigh, Hui Wang, Ping Cao, Andisheh Abedini
  • Patent number: 9813923
    Abstract: The present invention relates to the field of network communications, and discloses a duplex mode adaptive method, including: querying the modulation mode configuration table, to obtain a maximum modulation mode of the current duplex mode and a maximum modulation mode of the non-current duplex mode; calculating maximum spectral efficiency of the current duplex mode according to the maximum modulation mode of the current duplex mode; calculating maximum spectral efficiency of the non-current duplex mode according to the maximum modulation mode of the non-current duplex mode; comparing the maximum spectral efficiency of the current duplex mode with the maximum spectral efficiency of the non-current duplex mode, and selecting a duplex mode whose spectral efficiency is greater as a next-step duplex mode; and switching a duplex mode of the wireless communications apparatus to the next-step duplex mode.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: November 7, 2017
    Assignee: Huawei Technologies Co., Ltd.
    Inventors: Hongli Jiang, Huaping Qing, Ping Cao, Qiao Liu, Yu Liu
  • Publication number: 20170092653
    Abstract: In some examples, a fluid ejection device includes a substrate and a memory cell on the substrate, the memory cell including a first dielectric layer, a floating gate, a second dielectric layer, and a control gate. The memory cell includes a channel region between a drain region and a source region. The first dielectric layer is over the channel region and the floating gate is capacitively coupled to the channel region through the first dielectric layer. The floating gate includes a polysilicon layer, a metal layer, and a second dielectric layer between the polysilicon layer and the metal layer, where the second dielectric layer includes an opening through which the polysilicon layer is electrically connected to the metal layer.
    Type: Application
    Filed: December 14, 2016
    Publication date: March 30, 2017
    Inventors: Chaw Sing Ho, Reynaldo V. Villavelez, Xin Ping Cao
  • Publication number: 20170051032
    Abstract: The present disclosure provides for isolated non-naturally occurring, mutant-human IAPP polypeptides. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. The present disclosure also provides methods and compositions for treating amyloid-based disease in a subject in need thereof, comprising administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof.
    Type: Application
    Filed: May 1, 2015
    Publication date: February 23, 2017
    Applicant: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
    Inventors: Daniel RALEIGH, Hui WANG, Ping CAO, Andisheh ABEDINI
  • Patent number: 9559106
    Abstract: A memory cell including a substrate, a first dielectric layer, a floating gate, a second dielectric layer, and a control gate. The substrate includes a channel region situated between a drain region and a source region. The first dielectric layer is situated over the channel region and the floating gate is capacitively coupled to the channel region through the first dielectric layer. The second dielectric layer is situated over the floating gate and the control gate is capacitively coupled to the floating gate through the second dielectric layer. A dielectric nitride layer is situated between the floating gate and the second dielectric layer to prevent charge loss from the floating gate to the second dielectric layer.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: January 31, 2017
    Assignee: HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.
    Inventors: Chaw-Sing Ho, Reynaldo Villavelez, Xin Ping Cao
  • Publication number: 20160183105
    Abstract: The present invention relates to the field of network communications, and discloses a duplex mode adaptive method, including: querying the modulation mode configuration table, to obtain a maximum modulation mode of the current duplex mode and a maximum modulation mode of the non-current duplex mode; calculating maximum spectral efficiency of the current duplex mode according to the maximum modulation mode of the current duplex mode; calculating maximum spectral efficiency of the non-current duplex mode according to the maximum modulation mode of the non-current duplex mode; comparing the maximum spectral efficiency of the current duplex mode with the maximum spectral efficiency of the non-current duplex mode, and selecting a duplex mode whose spectral efficiency is greater as a next-step duplex mode; and switching a duplex mode of the wireless communications apparatus to the next-step duplex mode.
    Type: Application
    Filed: February 26, 2016
    Publication date: June 23, 2016
    Inventors: Hongli Jiang, Huaping Qing, Ping Cao, Qiao Liu, Yu Liu